Log In
Print
BCIQ
Print
Print this Print this
 

UroXatra, Uroxatral, Xatral, alfuzosin

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionOnce-daily controlled-release formulation of alfuzosin
Molecular Target Adrenergic receptor alpha 1 (ADRA1)
Mechanism of ActionAdrenergic receptor alpha 1 (ADRA1) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today